文献速递神经技术与安全MR

磁共振成像肿瘤栖息地分析鉴别立体定向放射外科治疗后脑转移瘤的肿瘤进展与放射性坏死

Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery.
PubMed 文献 · Eur Radiol · 2021-08-06

本研究纳入52例患者69个SRS后增大的强化病灶,基于多参数MRI的体素聚类构建结构MRI栖息地(强化、实性低强化、无活性)和生理MRI栖息地(富血供细胞、乏血供细胞、无活性),用逻辑回归筛选预测活肿瘤的栖息地指标,并在24例独立数据集中验证。结果显示仅结构MRI栖息地可预测活肿瘤,联合结构栖息地AUC在开发集为0.85、验证集为0.86,优于单一ADC(0.64)和CBV(0.58)。

要点

  • 结构MRI栖息地可帮助鉴别SRS后脑转移瘤的活肿瘤与放射性坏死。
  • 实性低强化栖息地(T2WI低信号、CE-T1WI低信号)对预测活肿瘤最有帮助(OR 1.74,p<.001)。
  • 进展部位与实性低强化栖息地匹配(72%,8/11),可提供空间定位信息。

核心结论

  • 结构MRI上的实性低强化栖息地和不可存活组织栖息地可帮助定位SRS后脑转移瘤患者的活肿瘤。

研究设计与样本

  • 纳入52例患者69个SRS后增大的强化病灶,获取多参数对比增强T1WI和T2WI、ADC及CBV,采用体素聚类识别3种结构MRI栖息地(强化、实性低强化、无活性)和3种生理MRI栖息地(富血供细胞、乏血供细胞、无活性),用逻辑回归筛选预测活肿瘤或放射性坏死的栖息地指标,并在24例独立数据集中用ROC曲线下面积验证性能。

关键影像表现/征象

  • 实性低强化栖息地表现为T2WI低值和CE-T1WI低值。
  • 无活性组织栖息地表现为T2WI高值和CE-T1WI低值。
  • 进展部位与实性低强化栖息地匹配(72%,8/11)。

诊断标准与关键数值

  • 实性低强化栖息地高体积分数预测活肿瘤(OR 1.74,p<.001)。
  • 无活性组织栖息地低体积分数预测活肿瘤(OR 0.55,p<.001)。
  • 联合结构MRI栖息地在开发集AUC 0.85(95%CI:0.77-0.94),在验证集AUC 0.86(95%CI:0.70-0.99)。
  • 单一ADC的AUC为0.64,单一CBV的AUC为0.58。
  • 生理MRI栖息地均不能提示活肿瘤。

临床应用与阅片要点

  • 结构MRI栖息地分析可用于SRS后增大的强化病灶中定位活肿瘤。
  • 实性低强化栖息地(T2WI低信号、CE-T1WI低信号)对寻找活肿瘤最有帮助。
  • 联合结构MRI栖息地 discriminatory 能力优于单一ADC和CBV值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The identification of viable tumor after stereotactic radiosurgery (SRS) is important for future targeted therapy. This study aimed to determine whether tumor habitat on structural and physiologic MRI can distinguish viable tumor from radiation necrosis of brain metastases after SRS.

METHOD: Multiparametric contrast-enhanced T1- and T2-weighted imaging, apparent diffusion coefficient (ADC), and cerebral blood volume (CBV) were obtained from 52 patients with 69 metastases, showing enlarging enhancing masses after SRS. Voxel-wise clustering identified three structural MRI habitats (enhancing, solid low-enhancing, and nonviable) and three physiologic MRI habitats (hypervascular cellular, hypovascular cellular, and nonviable). Habitat-based predictors for viable tumor or radiation necrosis were identified by logistic regression. Performance was validated using the area under the curve (AUC) of the receiver operating characteristics curve in an independent dataset with 24 patients.

RESULTS: None of the physiologic MRI habitats was indicative of viable tumor. Viable tumor was predicted by a high-volume fraction of solid low-enhancing habitat (low T2-weighted and low CE-T1-weighted values; odds ratio [OR] 1.74, p <.001) and a low-volume fraction of nonviable tissue habitat (high T2-weighted and low CE-T1-weighted values; OR 0.55, p <.001). Combined structural MRI habitats yielded good discriminatory ability in both development (AUC 0.85, 95% confidence interval [CI]: 0.77-0.94) and validation sets (AUC 0.86, 95% CI:0.70-0.99), outperforming single ADC (AUC 0.64) and CBV (AUC 0.58) values. The site of progression matched with the solid low-enhancing habitat (72%, 8/11).

CONCLUSION: Solid low-enhancing and nonviable tissue habitats on structural MRI can help to localize viable tumor in patients with brain metastases after SRS.

KEY POINTS: • Structural MRI habitats helped to differentiate viable tumor from radiation necrosis. • Solid low-enhancing habitat was most helpful to find viable tumor. • Providing spatial information, the site of progression matched with solid low-enhancing habitat.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee DH, Park JE, Kim N, et al. Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery. Eur Radiol. 2021. PMID: 34357451. doi:10.1007/s00330-021-08204-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。